Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients.

Klein C, Cavazzana-Calvo M, Le Deist F, Jabado N, Benkerrou M, Blanche S, Lisowska-Grospierre B, Griscelli C, Fischer A.

Blood. 1995 Jan 15;85(2):580-7. Review.

2.

HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases.

Giri N, Vowels M, Ziegler JB, Ford D, Lam-Po-Tang R.

Aust N Z J Med. 1994 Feb;24(1):26-30.

PMID:
8002854
3.

Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.

van Leeuwen JE, van Tol MJ, Joosten AM, Schellekens PT, van den Bergh RL, Waaijer JL, Oudeman-Gruber NJ, van der Weijden-Ragas CP, Roos MT, Gerritsen EJ, et al.

Blood. 1994 Dec 1;84(11):3936-47. Review.

5.

Detection of donor-derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantation.

Emile JF, Haddad E, Fraitag S, Canioni D, Fischer A, Brousse N.

Br J Haematol. 1997 Aug;98(2):480-4.

PMID:
9266954
6.

Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.

Haddad E, Landais P, Friedrich W, Gerritsen B, Cavazzana-Calvo M, Morgan G, Bertrand Y, Fasth A, Porta F, Cant A, Espanol T, Müller S, Veys P, Vossen J, Fischer A.

Blood. 1998 May 15;91(10):3646-53.

7.

Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.

Bertrand Y, Landais P, Friedrich W, Gerritsen B, Morgan G, Fasth A, Cavazzana-Calvo M, Porta F, Cant A, Espanol T, Müller S, Veys P, Vossen J, Haddad E, Fischer A.

J Pediatr. 1999 Jun;134(6):740-8.

PMID:
10356144
8.

Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.

Knutsen AP, Wall DA.

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):823-32.

PMID:
10329816
9.

Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.

Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.

Pediatrics. 1996 Sep;98(3 Pt 1):420-8.

PMID:
8784367
10.

Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.

Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD, Henslee-Downey J, Trigg ME, Cowan MJ, Sanders J, Bunin N, Weinstein H, Lenarsky C, Falk P, Harris R, Bowen T, Williams TE, Grayson GH, Warkentin P, Sender L, Cool VA, Crittenden M, Packman S, Kaplan P, Lockman LA, Anderson J, Krivit W, Dusenbery K, Wagner J.

Blood. 1996 Jun 1;87(11):4894-902.

11.
12.

Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group.

Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, Saunders EF, deAlarcon PA, Twist C, Nachman JB, Hale GA, Harris RE, Rozans MK, Kurtzberg J, Grayson GH, Williams TE, Lenarsky C, Wagner JE, Krivit W.

Blood. 1998 Apr 1;91(7):2601-8.

13.

Incomplete T-cell immune reconstitution in two major histocompatibility complex class II-deficiency/bare lymphocyte syndrome patients after HLA-identical sibling bone marrow transplantation.

Godthelp BC, van Eggermond MC, Peijnenburg A, Tezcan I, van Lierde S, van Tol MJ, Vossen JM, van den Elsen PJ.

Blood. 1999 Jul 1;94(1):348-58.

14.

[Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].

van Steekelenburg M, van Weel-Sipman MH, Zwinderman AH, Hoogerbrugge PM, Vossen JM, Egeler RM.

Ned Tijdschr Geneeskd. 2002 Aug 17;146(33):1542-6. Dutch.

PMID:
12212502
15.

Treatment of Omenn syndrome by bone marrow transplantation.

Gomez L, Le Deist F, Blanche S, Cavazzana-Calvo M, Griscelli C, Fischer A.

J Pediatr. 1995 Jul;127(1):76-81.

PMID:
7608815
16.

T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.

Smogorzewska EM, Brooks J, Annett G, Kapoor N, Crooks GM, Kohn DB, Parkman R, Weinberg KI.

Arch Immunol Ther Exp (Warsz). 2000;48(2):111-8.

PMID:
10807052
17.

Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.

Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Brown BS, Paul ME, Abramson SL, Ritz J, Shearer WT.

J Allergy Clin Immunol. 2008 Dec;122(6):1185-93. doi: 10.1016/j.jaci.2008.10.030.

PMID:
19084111
18.
19.

Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome.

Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C.

J Pediatr. 1993 Dec;123(6):921-8.

PMID:
8229525
20.

Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency.

Fischer A, Landais P, Friedrich W, Gerritsen B, Fasth A, Porta F, Vellodi A, Benkerrou M, Jais JP, Cavazzana-Calvo M, et al.

Blood. 1994 Feb 15;83(4):1149-54.

Items per page

Supplemental Content

Support Center